Aurobindo Pharma Ties Up with BIRAC to Develop Covid-19 Vaccine
4 years, 4 months ago

Aurobindo Pharma Ties Up with BIRAC to Develop Covid-19 Vaccine

News 18  

Aurobindo Pharma on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council, set up by the Department of Biotechnology for the development of Covid-19 vaccine. BIRAC has facilitated the establishment of ’the r-VSV vaccine’ manufacturing platform for the first time in India by supporting Aurobindo Pharma’s Covid-19 vaccine development, the company said in a regulatory filing. Commenting on the collaboration, Aurobindo Pharma Managing Director N Govindarajan said,” It is a matter of immense pride that BIRAC has placed its trust on our vaccine capabilities. The senior leadership of Aurobindo and Auro Vaccines has extensive experience in development, production and commercialization of several vaccines.” Department of Biotechnology Secretary and BIRAC Chairperson Renu Swarup said the partnership with Aurobindo is to serve the country’s need for a vaccine to fight this pandemic.

India Pharma Develop Aurobindo Vaccine Birac  vaccines  ties  vaccine  birac  pharma  biotechnology  aurobindo  viral  develop  swarup  development  covid19

History of this topic

Aurobindo Pharma launches COVID-19 drug Molnupiravir in India
3 years ago

Aurobindo Pharma launches COVID-19 drug Molnupiravir in India

Deccan Chronicle  

Hyderabad: Aurobindo Pharma Limited has launched COVID-19 treatment drug Molnupiravir under brand name "Molnaflu" in India. Earlier last year, Aurobindo had signed a bi-lateral non-exclusive voluntary licensing agreement with Merck Sharpe Dohme, Singapore, a subsidiary of Merck & Co. to manufacture and supply Molnupiravir to over 100 low and middle-income countries, including India. K Nithyananda Reddy, Vice Chairman and Managing …

Aurobindo Pharma to make COVAXX’s vaccine for India, UNICEF
4 years ago

Aurobindo Pharma to make COVAXX’s vaccine for India, UNICEF

The Hindu  

Aurobindo Pharma on Thursday said it had entered into an agreement to develop, commercialise and manufacture U.S. firm COVAXX’s COVID-19 vaccine candidate for India and the United Nations Children's Fund agency. Managing Director N.Govindarajan said “we are proud to partner with COVAXX in developing the first-ever synthetic peptide-based vaccine to combat the COVID-19 pandemic. This vaccine has immense potential in …

Aurobindo Pharma Expects to Commercialise Vaccine Facility by April-May 2021
4 years, 1 month ago

Aurobindo Pharma Expects to Commercialise Vaccine Facility by April-May 2021

News 18  

Aurobindo Pharma expects to commercialise its vaccine manufacturing facility in Hyderabad by April-May next year, according to a top company official. One in terms of our own vaccine, one in terms of tie-up with CSIR Labs, which in fact, there are three different products on three different platforms by three institutes," Aurobindo Pharma Managing Director N Govindarajan said in an …

Discover Related